EnBiotix, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
EnBiotix, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $263,500 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2022.
EnBiotix at a glance
What does EnBiotix do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $263,500 in total (2016). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $3.5 million sold (2022).
Frequently asked questions about EnBiotix
Where is EnBiotix headquartered?
EnBiotix, Inc. is headquartered in Boston, Massachusetts, United States.
What does EnBiotix do?
EnBiotix, Inc. is a pharmaceutical company.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences